IN8bio, Inc. (INAB)
Nasdaq: INAB · Biological Products, (No Diagnostic Substances) · New York, NY · filing with the SEC since 2018
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 12, 2026 | Mar 13, 2025 | Mar 14, 2024 | Mar 30, 2023 | Mar 17, 2022 | · |
| Research and development | 10,211 | 16,962 | 16,827 | 14,062 | 7,347 | 5,378 |
| General and administrative | 9,650 | 12,637 | 13,510 | 14,459 | 7,306 | 3,179 |
| Total operating expenses | 19,861 | 30,667 | 30,337 | 28,521 | 14,653 | 8,557 |
| Operating income | -19,440 | -30,437 | -30,007r | -28,521 | -14,653 | -8,557 |
| Interest and investment income | 421 | 230 | 0 | · | · | · |
| Income before income taxes | -19,440 | -30,676 | · | · | · | · |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income including non-controlling interests | -19,440 | -30,437 | -30,007 | -28,521 | -14,653 | -8,557 |
| Net income | -19,440 | -30,437 | -30,007 | -28,521 | -14,653 | -8,557 |
| Net income to common shareholders | · | · | · | · | -14,653 | -10,340 |
| Earnings per share, basic | -4.44 | -17.05r | -30.00b | -40.80b | -44.10b | · |
| Earnings per share, diluted | -4.44 | -17.05r | -30.00b | -40.80b | -44.10b | · |
| Earnings per share, basic and diluted | · | · | · | · | -44.10b | -90.60b |
| Weighted average shares, basic | 4,374,328 | 1,784,890r | 995,498b | 698,932b | 332,324b | · |
| Weighted average shares, diluted | 4,374,328 | 1,784,890r | 995,498b | 698,932b | 332,324b | · |
| Weighted average shares, basic and diluted | · | · | · | · | 332,324b | 113,969b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-30 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted